New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
10:07 EDTSCHW, VAR, ALKS, AMTD, AGN, CHMT, ETFCOn The Fly: Analysts Initiation Summary
Today's noteworthy initiations include: Allergan (AGN) initiated with a Buy at SunTrust...Varian Medical (VAR) initiated with a Buy at Benchmark Co. and with a Buy at SunTrust...E-Trade (ETFC) initiated with a Neutral at Compass Point...TD Ameritrade (AMTD) initiated with a Neutral at Compass Point...Charles Schwab (SCHW) initiated with a Neutral at Compass Point...Chemtura (CHMT) initiated with a Buy at KeyBanc...Alkermes (ALKS) initiated with a Buy at Mizuho.
News For AGN;VAR;ETFC;AMTD;SCHW;CHMT;ALKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 20, 2015
05:31 EDTAMTDTD Ameritrade downgraded to Neutral from Buy at Goldman
Subscribe for More Information
March 19, 2015
09:03 EDTSCHWAmerican Express, Charles Schwab confirm co-brand relationship
Subscribe for More Information
07:28 EDTSCHWAmerican Express, Charles Schwab reach co-brand agreement, Reuters says
American Express (AXP) stated Thursday it has reached a deal with Charles Schwab (SCHW) to offer cards under both company names, reports Reuters. The deal is a multi-year agreement and will involve two kinds of cards, though precise details will not be announced until near the expected launch date in early 2016. Reference Link
March 18, 2015
07:18 EDTETFC, AMTDWells Fargo to hold a forum
Subscribe for More Information
March 17, 2015
10:00 EDTSCHWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:13 EDTAGNActavis says Allergan CEO not joining combined company board
Subscribe for More Information
08:58 EDTAGNActavis sees double digit accretion to adjusted EPS within first 12 months
08:58 EDTAGNActavis says will 'immediately begin implementing' integration plans
Subscribe for More Information
08:57 EDTAGNActavis completes acquisition of Allergan
Actavis plc (ACT) announced that it has completed the acquisition of Allergan (AGN) in a cash and equity transaction valued at approximately $70.5B. The combination creates one of the world’s top 10 pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23B anticipated in 2015. Actavis continues to expect the transaction to generate double-digit accretion to non-GAAP earnings within the first 12 months, including approximately $1.8B in operating and financial synergies to be realized within one year following the close. These synergies exclude any additional revenue or manufacturing synergies, and are in addition to the $475M of annual savings previously announced by Allergan in connection with Project Endurance. Actavis further expects to generate strong operating cash flow in excess of $8B in 2016, which would enable the company to rapidly de-lever the balance sheet.
08:56 EDTAGNActavis completes Allergan acquisition valued at $70.5B
Subscribe for More Information
08:08 EDTVARVarian Medical to create operating entity in Algeria
Subscribe for More Information
07:51 EDTSCHWCharles Schwab upgraded at JMP Securities
Subscribe for More Information
06:05 EDTSCHWCharles Schwab upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information
March 16, 2015
18:38 EDTAGNAmerican Airlines to replace Allergan in S&P 500 as of 3/20 close
Subscribe for More Information
17:19 EDTAGNAmerican Airlines to replace Allergan in S&P 500 as of 3/20 close
10:22 EDTAGNEuropean Commission clears Actavis' pending acquisition of Allergan
Subscribe for More Information
10:14 EDTAGNOptions with decreasing implied volatility
Options with decreasing implied volatility: EXPR ULTA SGMS QIHU BKS PAY URBN AGN AGNC
March 13, 2015
08:47 EDTSCHWCharles Schwab says Q1 EPS running approx. 1c lower than year-ago results
Subscribe for More Information
08:46 EDTSCHWCharles Schwab reports February core net new assets $12.3B
Subscribe for More Information
08:08 EDTETFCE-Trade reports February daily average revenue trades 179,420
DARTs are down 11% y/y and up 4% from January. Added 37,224 gross new brokerage accounts in February, ending the month with approximately 3.2M brokerage accounts -- an increase of 20,715 from January. Net new brokerage assets were $1.7M in the month. During the month, customer security holdings increased by 6%, or $12.2B, and brokerage-related cash increased by $2.1B to $42.1B. Bank-related cash and deposits increased by $100M, ending the month at $5.8M. Customers were net sellers of approximately $800M in securities during the month.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use